Spero alert: bragar eagel & squire, p.c. is investigating spero therapeutics, inc. on behalf of long-term stockholders and encourages investors to contact the firm

New york--(business wire)-- #a--bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, is investigating potential claims against spero therapeutics, inc. (nasdaq: spro) on behalf of long-term stockholders following a class action complaint that was filed against spero with a class period from october 28, 2021 to may 2, 2022. our investigation concerns whether the board of directors of spero have breached their fiduciary duties to the company. spero, a clinical-stage bi.
SPRO Ratings Summary
SPRO Quant Ranking